Portland, Oregon – Frank X. Curci, a partner and bioscience, intellectual property and business attorney at the law firm of Ater Wynne LLP, has been re-elected to another term on the board of directors of Cancer Research And Biostatistics (CRAB®). Curci is also the chair of CRAB's Strategic Planning Committee.
CRAB is a nonprofit bioscience organization based in Seattle. CRAB's primary mission is to help conquer cancer by participating in key aspects of designing, conducting and analyzing the results arising out of cancer clinical trials. CRAB also takes a leadership role in forming collaborations and other strategic alliances with biopharmaceutical companies and other research institutions to foster cancer clinical trials and clinical drug development.
"Frank is a recognized bioscience and intellectual property attorney with a reputation for advising bioscience institutions regarding a wide range of scientific and medical research and technology issues, including forming bioscience collaborations and developing strategies for the protection and use of their data, technology and other IP rights," said Antje Hoering, Ph.D., President and CEO of CRAB. "Frank's experiences structuring bioscience collaborations and other research alliances, and advising bioscience entities regarding their overall IP strategies, are extremely valuable to CRAB because we are increasingly taking the leadership role in research collaborations."
"Frank's level of hands-on experience advising bioscience institutions is not common among attorneys," continued Dr. Hoering. "Frank has been a valuable Director on our Board because his expertise advising other bioscience institutions brings an important perspective to our Board of Directors and CRAB in general."
Curci focuses his practice in the areas of intellectual property, bioscience and technology law. He represents clients in both the bioscience and high technology industries. Curci's clients include research institutions, universities, technology incubators, high tech-industry companies, and other bioscience-industry companies.
Cancer Research And Biostatistics (CRAB) is a 501(c) (3) nonprofit bioscience organization based in Seattle, Washington. CRAB was founded in 1997 by John Crowley, PhD, an internationally renowned biostatistician. CRAB's primary mission is to help conquer cancer by participating in key aspects of designing, conducting, and analyzing the results arising out of cancer clinical trials. www.crab.org
Ater Wynne is a Pacific Northwest law firm that offers strategically focused advice and services in business, technology, bioscience, intellectual property, litigation, environmental, energy, global trade, employment, real estate, and health care law. www.aterwynne.com